Microbial Modulation of the Gut–Liver Axis in Autoimmune Liver Diseases
Seminars in Liver Disease · 01.12.2025 · 45 (04) · 498-516
DOI: 10.1055/a-2679-3641 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.12.2025. Verfasst von Shihui Wei und 1 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medi…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver, Hepatitis, Autoimmune, Cholangitis, Sclerosing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autoimmune liver diseases (AILDs), including autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis, are chronic inflammatory conditions influenced by complex interactions among genetic, environmental, and immunological factors. Recent studies have highlighted the critical role of the gut microbiota in regulating immune responses beyond the gastrointestinal tract via the gut–liver axis. This review examines the interactions between intestinal microecology and AILDs, with a focus on mechanisms such as bacterial translocation, disruption of the intestinal barrier, and modulation of microbial metabolites. Dysbiosis, involving alterations in both bacterial and fungal communities, has been associated with immune dysregulation and hepatic inflammation. Evidence indicates that short-chain fatty acids, bile acids, and microbial products such as lipopolysaccharides influence hepatic immune tolerance and inflammatory signaling pathways. Several diagnostic and therapeutic approaches, including probiotics, fecal microbiota transplantation, and bile acid regulation, have shown potential to slow or alter disease progression. However, the clinical translation of these findings remains limited due to interindividual variability and the complex nature of the gut–liver axis. Continued research is needed to develop precision medicine strategies that can harness intestinal microecology for improved management of AILDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center fo…
Zitieren
APA
Wei, S., & Lu, J. (2025). Microbial Modulation of the Gut–Liver Axis in Autoimmune Liver Diseases. Seminars in Liver Disease, 45(04), 498-516. https://doi.org/10.1055/a-2679-3641
Vancouver
Wei S, Lu J. Microbial Modulation of the Gut–Liver Axis in Autoimmune Liver Diseases. Seminars in Liver Disease. 2025;45(04):498-516. doi:10.1055/a-2679-3641
BibTeX
@article{Wei2025,
author = {Wei, Shihui and Lu, Juan},
title = {Microbial Modulation of the Gut–Liver Axis in Autoimmune Liver Diseases},
journal = {Seminars in Liver Disease},
year = {2025},
volume = {45},
number = {04},
pages = {498--516},
doi = {10.1055/a-2679-3641}
}
EUVIMED